help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Emori, T.
Right arrow Articles by Marumo, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Emori, T.
Right arrow Articles by Marumo, F.

Endocrinology, Vol 133, 2474-2480, Copyright © 1993 by Endocrine Society


ARTICLES

Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells

T Emori, Y Hirata, T Imai, S Eguchi, K Kanno and F Marumo
Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.

We studied the cellular mechanism by which natriuretic peptides inhibit the synthesis and release of endothelin-1 (ET-1) in cultured rat aortic endothelial cells (EC). Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) showed dose-dependent and equipotent effects on displacement of [125I]ANP binding and generation of cGMP production in rat EC, whereas C-type natriuretic peptide and biologically inactive ANP analog had lesser effects. ANP and BNP as well as 8-bromo-cGMP had potent inhibitory effects on immunoreactive ET-1 release, the transient increase in the intracellular Ca2+ concentration, and the formation of inositol 1,4,5-trisphosphate stimulated by thrombin in rat EC. A cGMP- dependent protein kinase inhibitor (KT5823), but not a cAMP-dependent protein kinase inhibitor (KT5720), completely abolished the inhibitory effect of ANP on thrombin-induced immunoreactive Et-1 release. Northern blot analysis using cDNA for rat prepro-ET-1 as a probe showed that ANP and 8-bromo-cGMP, but not C-type natriuretic peptide, inhibited thrombin-induced prepro-ET-1 mRNA expression, whose effect was abolished by KT5823. These data suggest that ANP and BNP inhibit the thrombin-induced synthesis and release of ET-1 in cultured rat aortic EC by blocking phosphoinositide breakdown, possibly via natriuretic peptides type A receptor-mediated cGMP-dependent mechanism.


This article has been cited by other articles:


Home page
Eur Heart JHome page
S. Kasama, M. Furuya, T. Toyama, S. Ichikawa, and M. Kurabayashi
Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction
Eur. Heart J., June 2, 2008; 29(12): 1485 - 1494.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Kasama, T. Toyama, T. Hatori, H. Sumino, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi
Effects of Intravenous Atrial Natriuretic Peptide on Cardiac Sympathetic Nerve Activity and Left Ventricular Remodeling in Patients With First Anterior Acute Myocardial Infarction
J. Am. Coll. Cardiol., February 13, 2007; 49(6): 667 - 674.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Ozawa, M. Shichiri, N. Fukai, T. Yoshimoto, and Y. Hirata
Regulation of Adrenomedullin Gene Transcription and Degradation by the c-myc Gene
Endocrinology, September 1, 2004; 145(9): 4244 - 4250.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. ANTUNES-RODRIGUES, M. DE CASTRO, L. L. K. ELIAS, M. M. VALENCA, and S. M. McCANN
Neuroendocrine Control of Body Fluid Metabolism
Physiol Rev, January 1, 2004; 84(1): 169 - 208.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Sabrane, S. Gambaryan, R. P. Brandes, R. Holtwick, M. Voss, and M. Kuhn
Increased Sensitivity to Endothelial Nitric Oxide (NO) Contributes to Arterial Normotension in Mice with Vascular Smooth Muscle-selective Deletion of the Atrial Natriuretic Peptide (ANP) Receptor
J. Biol. Chem., May 9, 2003; 278(20): 17963 - 17968.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. P.B. Wijayagunawardane, A. Miyamoto, Y. Taquahashi, T. J. Acosta, M. Nishimura, and K. Sato
Angiotensin II and Atrial Natriuretic Peptide in the Cow Oviductal Contraction In Vitro: Direct Effect and Local Secretion of Prostaglandins, Endothelin-1, and Angiotensin II
Biol Reprod, September 1, 2001; 65(3): 799 - 804.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Hayashi, T. Tsutamoto, A. Wada, K. Maeda, N. Mabuchi, T. Tsutsui, H. Horie, M. Ohnishi, and M. Kinoshita
Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction
J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1820 - 1826.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
L. G. MELO, M. E. STEINHELPER, S. C. PANG, Y. TSE, and U. ACKERMANN
ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models
Physiol Genomics, June 29, 2000; 3(1): 45 - 58.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. E. Sviri, M. Feinsod, and J. F. Soustiel
Brain Natriuretic Peptide and Cerebral Vasospasm in Subarachnoid Hemorrhage : Clinical and TCD Correlations
Stroke, January 1, 2000; 31(1): 118 - 122.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. van der Zander, A. J.H.M Houben, A. A Kroon, and P. W de Leeuw
Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide
Cardiovasc Res, December 1, 1999; 44(3): 595 - 600.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Zellner, A. A. Protter, E. Ko, M. R. Pothireddy, T. DeMarco, S. J. Hutchison, T. M. Chou, K. Chatterjee, and K. Sudhir
Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries
Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H1049 - H1057.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Suenobu, M. Shichiri, M. Iwashina, F. Marumo, and Y. Hirata
Natriuretic Peptides and Nitric Oxide Induce Endothelial Apoptosis via a cGMP–Dependent Mechanism
Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 140 - 146.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. L. Bouchie, H. Hansen, and E. P. Feener
Natriuretic Factors and Nitric Oxide Suppress Plasminogen Activator Inhibitor-1 Expression in Vascular Smooth Muscle Cells : Role of cGMP in the Regulation of the Plasminogen System
Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1771 - 1779.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. G. Melo, A. T. Veress, U. Ackermann, and H. Sonnenberg
Chronic regulation of arterial blood pressure by ANP: role of endogenous vasoactive endothelial factors
Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1826 - H1833.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Shichiri, S. Adachi, J. M. Sedivy, F. Marumo, and Y. Hirata
Biphasic Regulation of the Preproendothelin-1 Gene by c-myc
Endocrinology, November 1, 1997; 138(11): 4584 - 4590.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Shichiri, H. Kato, F. Marumo, and Y. Hirata
Endothelin-1 as an Autocrine/Paracrine Apoptosis Survival Factor for Endothelial Cells
Hypertension, November 1, 1997; 30(5): 1198 - 1203.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
H. Kato, M. Shichiri, F. Marumo, and Y. Hirata
Adrenomedullin as an Autocrine/Paracrine Apoptosis Survival Factor for Rat Endothelial Cells
Endocrinology, June 1, 1997; 138(6): 2615 - 2620.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Draijer, A. B. Vaandrager, C. Nolte, H. R. de Jonge, U. Walter, and V. W.M. van Hinsbergh
Expression of cGMP-Dependent Protein Kinase I and Phosphorylation of Its Substrate, Vasodilator-Stimulated Phosphoprotein, in Human Endothelial Cells of Different Origin
Circ. Res., November 1, 1995; 77(5): 897 - 905.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society